Tandem Diabetes Care (NASDAQ:TNDM) Coverage Initiated by Analysts at Canaccord Genuity Group
Canaccord Genuity Group began coverage on shares of Tandem Diabetes Care (NASDAQ:TNDM – Free Report) in a research note issued to investors on Thursday, Marketbeat Ratings reports. The brokerage issued a buy rating and a $57.00 price target on the medical device company’s stock. Several other brokerages have also commented on TNDM. Leerink Partnrs upgraded […]
More Stories
Beyond Hormuz: The US–Indonesia Defense Pact and What It Means for China
By Antonio Graceffo The U.S.–Indonesia defense pact strengthens American strategic control over key maritime chokepoints, enhancing its ability to pressure...
Iran Signals It May Skip Next US-Led Peace Talks as Israel Warns of Renewed Fighting
By Tom Ozimek Iran signaled fresh uncertainty around U.S.-backed peace efforts on April 20, saying it has yet to decide...
Is Love Story Season 2 Renewed? Release Date, Cast, and Spoiler
Ryan Murphy’s latest series, Love Story Season 1, has raised the bar with the 90’s romance featuring Sarah Pidgeon and...
Fifty Shades of Grey Star, Dakota Johnson, Net Worth and Salary in 2026
The Fifty Shades of Grey lead actress is once again in the spotlight after she appeared kissing her recent boyfriend,...
CapCut Vs InShot: Which is the Best Video Editing Tool?
Videos have become one of the most useful and important tools for every marketing organization. In this digital era, more...
Louisiana Gunman Kills at Least 8 Children in Morning Shooting Spree
By Jacki Thrapp At least eight children were killed during a shooting in Shreveport, Louisiana, on the morning of April...